首页> 外文期刊>Prenatal Diagnosis >Response to 'concerns about the statistical methodology described in the 'Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors''
【24h】

Response to 'concerns about the statistical methodology described in the 'Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11105 pregnancies with mixed risk factors''

机译:回应“对'基于大规模并行测序的产前无创胎儿三体检验在11105个三体综合症中混合风险因素的临床应用中所描述的统计方法的担忧”的11105孕妇中的回答

获取原文
获取原文并翻译 | 示例
       

摘要

Thanks a lot for your comments on the publication by Dan et al} We have read carefully through your comments and responded as follows:Firstly, the statistical methodology by Jiang et al.2 that we described is the original version of our bioinformatics analysis approach. For your comments on cell-free fetal DNA (cff-DNA) concentration, we agree with you that the cff-DNA concentration is of significance to non-invasive prenatal test (NIPT). Therefore, we do demonstrate the approach to estimate cff-DNA concentration in this article. There was a typographical error in the published formula in the article by Jiang et al where the subscript T should be 'X'.
机译:非常感谢您对Dan等人的出版物的评论}我们已经仔细阅读了您的评论,并做出如下回应:首先,我们描述的Jiang等人2的统计方法是我们生物信息学分析方法的原始版本。对于您对无细胞胎儿DNA(cff-DNA)浓度的评论,我们同意您的看法,即cff-DNA浓度对无创性产前检查(NIPT)具有重要意义。因此,我们在本文中确实演示了估算cff-DNA浓度的方法。 Jiang等人在文章中发表的公式中存在印刷错误,其中下标T应该为“ X”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号